Table 1.
Characteristics | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 |
---|---|---|---|---|---|---|
Gender | F | F | F | M | F | F |
Age at repeat decompression (years) | 62 | 62 | 50 | 55 | 58 | 63 |
Race | Caucasian | Caucasian | Caucasian | African- American |
African- American |
Caucasian |
Smoker status at time of decompression | N | N | Y | Y | Y | N |
Thyroid disease status at time of presentation |
Euthyroid | Euthyroid | Euthyroid | Euthyroid | Euthyroid | Euthyroid |
Duration of GO1
at repeat decompression (years) |
25 | 2 | 8 | 15 | 15 | 16 |
Time between initial decompression and presentation for recurrent/persistent CON2 symptoms (years) |
5.5 | 1 | 7 | 15 | 11 | 12 |
Duration of CON2
symptoms at presentation (months) |
6 | 12 | 6 | 2–3 | 12 | 1 |
CAS3 at presentation | 4/10 | 5/10 | 3/10 | 1/10 | 6/10 | 3/10 |
Prior or present steroid | No | No | Yes | Yes | No | No |
Laterality of repeat CON2 | Bilateral | Bilateral | Bilateral | Unilateral | Unilateral | Unilateral |
Abbreviations: Dt, date; BCVA, best corrected visual acuity; RAPD, relative afferent pupillary defect; MD, mean deviation.
Graves' Ophthalmopathy
Compressive Optic Neuropathy
Clinical Activity Score